Daito Pharmaceutical Co (TSE:4577) Change In Working Capital : 円0 Mil (TTM As of May. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Daito Pharmaceutical Co Change In Working Capital?

Daito Pharmaceutical Co's change in working capital for the quarter that ended in May. 2024 was 円0 Mil.

Daito Pharmaceutical Co's change in working capital for the fiscal year that ended in May. 2024 was 円-1,126 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).

Daito Pharmaceutical Co Change In Working Capital Historical Data

The historical data trend for Daito Pharmaceutical Co's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daito Pharmaceutical Co Change In Working Capital Chart

Daito Pharmaceutical Co Annual Data

Trend

May15

May16

May17

May18

May19

May20

May21

May22

May23

May24

Change In Working Capital

Get a 7-Day Free Trial

-4,220.19

-1,583.00

-4,399.00

-2,326.00

-1,126.00

Daito Pharmaceutical Co Quarterly Data
	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24
Change In Working Capital	Get a 7-Day Free Trial															-	-	-	-	-

Daito Pharmaceutical Co Change In Working Capital Calculation

Change In Working Capital for the trailing twelve months (TTM) ended in May. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows	Fiscal Years Ended	January 31,	(Amounts in millions)
Cash flows from operating activities:	2014	2013	2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net	(566)	(614)	(796)
Inventories	(1,667)	(2,759)	(3,727)
Accounts payable	531	1,061	2,687
Accrued liabilities	103	271	(935)
Accrued income taxes	(1,224)	981	994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

Daito Pharmaceutical Co Change In Working Capital Related Terms

Thank you for viewing the detailed overview of Daito Pharmaceutical Co's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Daito Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daito Pharmaceutical Co Ltd (TSE:4577) » Definitions » Change In Working Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

326 Yokamachi, Toyama, JPN, 939-8567

Website

http://www.daitonet.co.jp

Daito Pharmaceutical Co Ltd is engaged in the research and development of pharmaceutical products. The company also undertakes contract manufacturing.

Daito Pharmaceutical Co Headlines

No Headlines